Subscribe to RSS
DOI: 10.4103/ijri.IJRI_252_18
Outcome of conventional transarterial chemoembolization (cTACE) in the management of spontaneously ruptured hepatocellular carcinoma
Subject Editor: Financial support and sponsorship Nil.
Abstract
Background and Objectives: Hepatocellular carcinoma (HCC) is a highly vascular tumor and mortality after spontaneous rupture of HCC remains considerably high. There are no definitive guidelines for the management of ruptured HCC and no fixed protocol has been proposed in the literature. We evaluated the outcome of conventional transarterial chemoembolization (cTACE) in the management of spontaneously ruptured HCC and factors affecting the outcome of cTACE. Materials and Methods: This is a single center retrospective study analyzing the outcome of patients presenting with spontaneous rupture of HCC who received cTACE from January 2014 to June 2017. These patients were followed up periodically for clinical and imaging findings to ascertain the technical effectiveness along with survival. Results: Sixteen patients were identified who received cTACE for ruptured HCC. Majority of the patients (81.3%) had abdominal pain, while 25% had hypovolemic shock at initial presentation. Complete response and partial response were seen in 35.7% and 57.1% of patients, respectively. One patient (7.1%) showed progressive disease in form of peritoneal spread along the liver surface. The overall cumulative survival rates at 30 days, 180 days, and at 1 year were 87.5%, 72.2%, and 54.1%, respectively. Conclusion: cTACE is safe in patients with spontaneous HCC rupture and it leads to immediate hemostasis along with overall survival advantage. Achieving quick hemostasis may be a key to better outcome.
Keywords
Conventional transarterial chemoembolization - hepatocellular carcinoma - ruptured hepatocellular carcinomaPublication History
Article published online:
22 July 2021
© 2019. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
-
References
- 1 Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17
- 2 Yoshida H, Mamada Y, Taniai N, Uchida E. Spontaneous ruptured hepatocellular carcinoma. Hepatol Res 2016; 46: 13-21
- 3 Lai EC, Lau WY. Spontaneous rupture of hepatocellular carcinoma- A systematic review. Arch Surg 2006; 141: 191-8
- 4 Zhu LX, Geng XP, Fan ST. Spontaneous rupture of hepatocellular carcinoma and vascular injury. Arch Surg 2001; 136: 682-7
- 5 Zhu LX, Liu Y, Fan ST. Ultrastructural study of the vascular endothelium of patients with spontaneous rupture of hepatocellular carcinoma. Asian J Surg 2002; 25: 157-62
- 6 Vergara V, Muratore A, Bouzari H, Polastri R, Ferrero A, Galatola G. et al. Spontaneous rupture of hepatocellular carcinoma: Surgical resection and long-term survival. Eur J Surg Oncol 2000; 26: 770-2
- 7 Liu CL, Fan ST, Lo CM, Tso WK, Poon RT, Lam CM. et al. Management of spontaneous rupture of hepatocellular carcinoma: Single-center experience. J Clin Oncol 2001; 19: 3725-32
- 8 Moris D, Chakedis J, Sun SH, Spolverato G, Tsilimigras DI, Ntanasis-Stathopoulos I. et al. Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review. J Surg Oncol 2018; 117: 341-53
- 9 Sahu SK, Chawla YK, Dhiman RK, Singh V, Duseja A, Taneja S. et al. Rupture of hepatocellular carcinoma: A review of literature. J Clin Exp Hepatol 2018;
- 10 Miyamoto M, Sudo T, Kuyama T. Spontaneous rupture of hepatocellular carcinoma: A review of 172 Japanese cases. Am J Gastroenterol 1991; 86: 67-71
- 11 Xu HS, Yan JB. Conservative management of spontaneous ruptured hepatocellular carcinoma. Am Surg 1994; 60: 629-33
- 12 Okazaki M, Higashihara H, Koganemaru F, Nakamura T, Kitsuki H, Hoashi T. et al. Intraperitoneal hemorrhage from hepatocellular carcinoma: Emergency chemoembolization or embolization. Radiology 1991; 180: 647-51
- 13 Castells L, Moreiras M, Quiroga S, Alvarez-Castells A, Segarra A, Esteban R. et al. Hemoperitoneum as a first manifestation of hepatocellular carcinoma in western patients with liver cirrhosis: Effectiveness of emergency treatment with transcatheter arterial embolization. Dig Dis Sci 2001; 46: 555-62
- 14 Leung CS, Tang CN, Fung KH, Li MKW. A retrospective review of transcatheter hepatic arterial embolization for ruptured hepatocellular carcinoma. J R Coll Surg Edinb 2002; 47: 685-8
- 15 Yang H, Chen K, Wei Y, Liu F, Li H, Zhou Z. et al. Treatment of spontaneous ruptured hepatocellular carcinoma: A single-center study. Pak J Med Sci 2014; 30: 472-6
- 16 Sato Y, Fujiwara K, Furui S, Ogata I, Oka Y, Hayashi S. et al. Benefit of transcatheter arterial embolization for ruptured hepatocellular carcinoma complicating liver cirrhosis. Gastroenterology 1985; 89: 157-9
- 17 Ngan H, Tso WK, Lai CL, Fan ST. The role of hepatic arterial embolization in the treatment of spontaneous rupture of hepatocellular carcinoma. Clin Radiol 1998; 53: 338-41
- 18 Kim JY, Lee JS, Oh DH, Yim YH, Lee HK. Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2012; 24: 640-5